OMIDRIA

Brand name authorized in: Austria Ireland Lithuania United States

Active ingredients

The drug OMIDRIA contains a combination of these active pharmaceutical ingredients (APIs):

1 Phenylephrine
UNII 1WS297W6MV - PHENYLEPHRINE

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

Read about Phenylephrine
2 Ketorolac
UNII YZI5105V0L - KETOROLAC

Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.

Read about Ketorolac

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Phenylephrine and ketorolac
S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FB Sympathomimetics excl. antiglaucoma preparations
Discover more medicines within S01FB51

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1077848
US
FDA, National Drug Code
Identifier(s): 62225-600